Noureddin M - Search Results

1

Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)?

Ritchie M, Hanouneh IA, Noureddin M, Rolph T, Alkhouri N. Ritchie M, et al. Among authors: noureddin m. Expert Opin Investig Drugs. 2020 Feb;29(2):197-204. doi: 10.1080/13543784.2020.1718104. Epub 2020 Jan 22. Expert Opin Investig Drugs. 2020. PMID: 31948295 Review.

2

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.

Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, Loomba R. Noureddin M, et al. Hepatology. 2013 Dec;58(6):1930-40. doi: 10.1002/hep.26455. Epub 2013 Oct 17. Hepatology. 2013. PMID: 23696515 Free PMC article. Clinical Trial.

3

Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Noureddin M, Mato JM, Lu SC. Noureddin M, et al. Exp Biol Med (Maywood). 2015 Jun;240(6):809-20. doi: 10.1177/1535370215579161. Epub 2015 Apr 13. Exp Biol Med (Maywood). 2015. PMID: 25873078 Free PMC article. Review.

4

Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.

Noureddin M, Rinella ME. Noureddin M, et al. Clin Liver Dis. 2015 May;19(2):361-79. doi: 10.1016/j.cld.2015.01.012. Epub 2015 Mar 12. Clin Liver Dis. 2015. PMID: 25921668 Free PMC article. Review.

5

Promising therapies for treatment of nonalcoholic steatohepatitis.

Noureddin M, Zhang A, Loomba R. Noureddin M, et al. Expert Opin Emerg Drugs. 2016 Sep;21(3):343-57. doi: 10.1080/14728214.2016.1220533. Epub 2016 Aug 28. Expert Opin Emerg Drugs. 2016. PMID: 27501374 Free PMC article. Review.

6

Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Han MA, Saouaf R, Ayoub W, Todo T, Mena E, Noureddin M. Han MA, et al. Among authors: noureddin m. Expert Rev Clin Pharmacol. 2017 Apr;10(4):379-390. doi: 10.1080/17512433.2017.1299573. Epub 2017 Mar 9. Expert Rev Clin Pharmacol. 2017. PMID: 28277807 Free PMC article. Review.

7

The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Shouhed D, Steggerda J, Burch M, Noureddin M. Shouhed D, et al. Among authors: noureddin m. Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):797-811. doi: 10.1080/17474124.2017.1355731. Epub 2017 Jul 21. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28712339 Review.

8

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.

Noureddin M, Vipani A, Bresee C, Todo T, Kim IK, Alkhouri N, Setiawan VW, Tran T, Ayoub WS, Lu SC, Klein AS, Sundaram V, Nissen NN. Noureddin M, et al. Am J Gastroenterol. 2018 Nov;113(11):1649-1659. doi: 10.1038/s41395-018-0088-6. Epub 2018 Jun 8. Am J Gastroenterol. 2018. PMID: 29880964 Free PMC article.

9

Editorial: role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD).

Noureddin M, Loomba R. Noureddin M, et al. Aliment Pharmacol Ther. 2018 Aug;48(3):378-379. doi: 10.1111/apt.14819. Aliment Pharmacol Ther. 2018. PMID: 29998503 No abstract available.

10

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment.

Alkhouri N, Lawitz E, Noureddin M. Alkhouri N, et al. Among authors: noureddin m. Hepatol Commun. 2019 Mar 28;3(5):605-613. doi: 10.1002/hep4.1342. eCollection 2019 May. Hepatol Commun. 2019. PMID: 31061949 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters